Robertson, K. A., Nalepa, G., Yang, F., Bowers, D. C., Ho, C. Y., Hutchins, G. D., . . . Clapp, D. W. (2012). Pilot Phase II Trial of Imatinib Mesylate in Neurofibromatosis Type 1 patients with Plexiform Neurofibromas. Lancet Oncol.
Citação norma ChicagoRobertson, Kent A., et al. "Pilot Phase II Trial of Imatinib Mesylate in Neurofibromatosis Type 1 Patients With Plexiform Neurofibromas." Lancet Oncol 2012.
MLA CitationRobertson, Kent A., et al. "Pilot Phase II Trial of Imatinib Mesylate in Neurofibromatosis Type 1 Patients With Plexiform Neurofibromas." Lancet Oncol 2012.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.